We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 05, 2022

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy vs Observation in Oligometastatic Prostate Cancer

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
J. Clin. Oncol 2022 Aug 24;[EPub Ahead of Print], MP Deek, K Van der Eecken, P Sutera, RA Deek, V Fonteyne, AA Mendes, K Decaestecker, AP Kiess, N Lumen, R Phillips, A De Bruycker, M Mishra, Z Rana, J Molitoris, B Lambert, L Delrue, H Wang, K Lowe, S Verbeke, J Van Dorpe, R Bultijnck, G Villeirs, K De Man, F Ameye, DY Song, T DeWeese, CJ Paller, FY Feng, A Wyatt, KJ Pienta, M Diehn, SM Bentzen, S Joniau, F Vanhaverbeke, G De Meerleer, ES Antonarakis, TL Lotan, A Berlin, S Siva, P Ost, PT Tran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading